Back

Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient

European Heart Journal - Cardiovascular Pharmacotherapy

5 January 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Stefan Agewall
Stefan Agewall

Author

Karolinska Institute Stockholm , Sweden

You may be interested in
thumbnail
Congress Presentation
Antiplatelet strategies
26 March 2023
thumbnail
Congress Presentation
Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital
21 March 2026
thumbnail
Congress Presentation
Safety of dual antiplatelet pre-treatment in ACS patients undergoing unplanned aortocoronary bypass surgery
15 March 2025
thumbnail
Congress Presentation
Portuguese experience with dual and triple therapy in atrial fibrillation and acute coronary syndrome patients
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources